Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Suppression Of Atrial Fibrillation With Ranolazine After Cardiac Surgery

NCT01352416 is registered in ClinicalTrials.gov with Corewell Health East as lead sponsor.

NCT NCT01352416
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01352416 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Suppression Of Atrial Fibrillation With Ranolazine After Cardiac Surgery
Lead sponsor
Corewell Health East
Phase
Phase 3
Overall status
Terminated
Start date
September 30, 2010
Completion date
November 30, 2012
Enrollment
15 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

heart; dysfunction postoperative, cardiac surgery